Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Warrior Met Coal
HCC
$4.74B
| $24.2M | ﹤0.01% |
379,798
-198,440
| -34% | -$11.3M |
|
|
CON
2077
Concentra Group Holdings
CON
$4.44B
| $24.1M | ﹤0.01% |
1,153,328
-241,857
| -17% | -$5.16M |
|
2078
PUT
Trade Desk
TTD
$6.61B
| $24.1M | ﹤0.01% |
492,400
-675,700
| -58% | -$42.9M |
|
2079
CALL
CrowdStrike
CRWD
$217B
| $24.1M | ﹤0.01% |
196,800
+102,400
| +108% | +$11.6M |
|
2080
Acuity Brands
AYI
$10.8B
| $24.1M | ﹤0.01% |
70,033
-32,616
| -32% | -$10.4M |
|
2081
Cleveland-Cliffs
CLF
$6.99B
| $24.1M | ﹤0.01% |
1,976,001
-854,496
| -30% | -$8.99M |
|
2082
Dyne Therapeutics
DYN
$4.75B
| $24M | ﹤0.01% |
1,900,215
+559,772
| +42% | +$6.38M |
|
2083
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $24M | ﹤0.01% |
1,189,900
+1,050,000
| +751% | +$18.4M |
|
|
RAL
2084
Ralliant Corp
RAL
$7.47B
| $24M | ﹤0.01% |
549,451
-165,746
| -23% | -$7.37M |
|
2085
Louisiana-Pacific
LPX
$5.41B
| $24M | ﹤0.01% |
270,449
-56,069
| -17% | -$5.18M |
|
2086
Brookfield Renewable
BEPC
$6.22B
| $24M | ﹤0.01% |
697,697
-168,043
| -19% | -$5.76M |
|
|
GLXY
2087
PUT
Galaxy Digital Inc
GLXY
$4.06B
| $24M | ﹤0.01% |
+710,000
| New | +$19.1M |
|
2088
Braze
BRZE
$2.98B
| $24M | ﹤0.01% |
843,928
+561,671
| +199% | +$15.9M |
|
2089
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
| $24M | ﹤0.01% |
200,699
-220,401
| -52% | -$26.2M |
|
2090
Cemex
CX
$16.3B
| $24M | ﹤0.01% |
2,666,674
-3,242,891
| -55% | -$27.7M |
|
|
BCPC
2091
Balchem Corp
BCPC
$5.74B
| $24M | ﹤0.01% |
159,725
+10,591
| +7% | +$1.67M |
|
2092
PUT
Pfizer
PFE
$151B
| $24M | ﹤0.01% |
940,000
-244,300
| -21% | -$6.03M |
|
|
PRO
2093
DELISTED
PROS Holdings
PRO
| $23.9M | ﹤0.01% |
1,045,164
+177,524
| +20% | +$2.89M |
|
2094
Immunovant
IMVT
$8.12B
| $23.9M | ﹤0.01% |
1,482,539
+287,023
| +24% | +$4.65M |
|
2095
Zurn Elkay Water Solutions
ZWS
$8.54B
| $23.9M | ﹤0.01% |
507,704
+25,919
| +5% | +$1.12M |
|
2096
CALL
Suncor Energy
SU
$71.3B
| $23.9M | ﹤0.01% |
571,000
+100,000
| +21% | +$4.01M |
|
2097
Cogent Biosciences
COGT
$7.2B
| $23.8M | ﹤0.01% |
1,659,677
+459,240
| +38% | +$5.44M |
|
2098
Apogee Therapeutics
APGE
$10.2B
| $23.8M | ﹤0.01% |
599,616
-59,570
| -9% | -$2.27M |
|
2099
Equinox Gold
EQX
$13.6B
| $23.8M | ﹤0.01% |
2,122,842
-11,888,746
| -85% | -$94.6M |
|
|
ETNB
2100
DELISTED
89bio
ETNB
| $23.8M | ﹤0.01% |
1,616,785
+363,700
| +29% | +$3.71M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.